The Effect of Nalbuphine Extended-Release (NAL ER) on Cough in Participants With Refractory Chronic Cough (RCC)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to evaluate the efficacy and safety of Nalbuphine ERExtended‐release tablets for the treatment of participants with RCC.
Epistemonikos ID: de12e814ef389d0a2a22a6d44d6ec60df4e6d80a
First added on: Jun 27, 2026